9MX1

Clostridioides difficile Toxin A with mCDIFA-248-25 Fab

9MX1 の概要

• エントリーDOI: 10.2210/pdb9mx1/pdb
• EMDBエントリー: 48707
• 分子名称: Toxin A, mCDIFA-248-25 Fab Heavy Chain, mCDIFA-248-25 Fab Light Chain (3 entities in total)
• 機能のキーワード: toxin a, tcda, c.diff, complex, transferase, toxin-immune system complex, toxin/immune system
• 由来する生物種: Clostridioides difficile; 詳細
• タンパク質・核酸の鎖数: 3
• 化学式量合計: 355712.00

構造登録者

Huynh, K.W.,Ammirati, M.,Kroh, H.K.,Lacy, D.B.,Han, S. (登録日: 2025-01-17, 公開日: 2025-07-09, 最終更新日: 2025-10-29)

主引用文献

Kroh, H.K.,Jensen, J.L.,Wellnitz, S.,Park, J.J.,Esadze, A.,Huynh, K.W.,Ammirati, M.,Han, S.,Anderson, A.S.,Lacy, D.B.,Gribenko, A.
Mouse monoclonal antibodies against Clostridioides difficile toxins TcdA and TcdB target diverse epitopes for neutralization.
Infect.Immun., 93:e0013925-e0013925, 2025

PubMed Abstract: is a spore-forming, Gram-positive bacterium that can cause infections in subjects with weakened immune system or following antibiotic treatment. These infections may lead to pseudomembranous colitis and antibiotic-associated diarrhea in humans. As such, is a major cause of nosocomial illness worldwide. Major virulence factors of the bacterium are the large clostridium toxins A (TcdA) and B (TcdB)-high molecular mass proteins with intrinsic glucosyltransferase activity. Toxins bind to the intestinal epithelium and undergo endocytosis by the epithelial cells, followed by a conformational change triggered by the low pH of early endosomes. This conformational change leads to the exposure of hydrophobic segments, followed by membrane insertion, formation of pores, and translocation of the glucosyltransferase domain into the cellular cytoplasm. Once in the cytoplasm, the glucosyltransferase domain inactivates small GTPases of the Rho family of proteins, leading to the disruption of the cytoskeleton. In the current work, we describe the discovery and characterization of a panel of neutralizing mouse monoclonal antibodies capable of interfering with several steps of cellular intoxication by the toxins. The antibodies were produced using hybridoma technology. Neutralizing activity of the antibodies was confirmed using toxin neutralization assays, and functional assays were used to identify specific neutralization mechanisms. Binding epitopes of the antibodies were identified by hydrogen-deuterium exchange mass spectrometry and confirmed through negative-stain and cryo-electron microscopy. Together, our results show that full-length toxins and/or genetically- and chemically-modified toxoids can induce a wide spectrum of antibodies capable of neutralizing the toxins via a variety of mechanisms.

PubMed: 40844461
DOI: 10.1128/iai.00139-25

実験手法

ELECTRON MICROSCOPY (3.2 Å)